Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes - PubMed (original) (raw)
Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes
I Giardino et al. J Clin Invest. 1994 Jul.
Abstract
Intracellular sugars are more reactive glycosylating agents than glucose. In vitro nonezymatic glycosylation of basic fibroblast growth factor (bFGF) by fructose, glucose-6-phosphate (G6P), or glyceraldehyde-3-phosphate (G3P) reduced high affinity heparin-binding activity of recombinant bFGF by 73, 77, and 89%, respectively. Mitogenic activity was reduced 40, 50, and 90%. To investigate the effects of bFGF glycosylation in GM7373 endothelial cells, we first demonstrated that GLUT-1 transporters were not downregulated by increased glucose concentration. In 30 mM glucose, the rate of glucose transport increased 11.6-fold, and the intracellular glucose concentration increased sixfold at 24 h and fivefold at 168 h. The level of total cytosolic protein modified by advanced glycosylation end-products (AGEs) was increased 13.8-fold at 168 h. Under these conditions, mitogenic activity of endothelial cell cytosol was reduced 70%. Anti-bFGF antibody completely neutralized the mitogenic activity at both 5 and 30 nM glucose, demonstrating that all the mitogenic activity was due to bFGF. Immunoblotting and ELISA showed that 30 mM glucose did not decrease detectable bFGF protein, suggesting that the marked decrease in bFGF mitogenic activity resulted from posttranslational modification of bFGF induced by elevated glucose concentration. Cytosolic AGE-bFGF was increased 6.1-fold at 168 h. These data are consistent with the hypothesis that nonenzymatic glycosylation of intracellular protein alters vascular cell function.
Comment in
- AGEing growth factors: a role in diabetic vascular disease?
Baynes JW. Baynes JW. J Clin Invest. 1994 Jul;94(1):2. doi: 10.1172/JCI117307. J Clin Invest. 1994. PMID: 8040261 Free PMC article. No abstract available.
Similar articles
- Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation.
Nissen NN, Shankar R, Gamelli RL, Singh A, DiPietro LA. Nissen NN, et al. Biochem J. 1999 Mar 15;338 ( Pt 3)(Pt 3):637-42. Biochem J. 1999. PMID: 10051433 Free PMC article. - Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
Rusnati M, Urbinati C, Presta M. Rusnati M, et al. J Cell Physiol. 1993 Jan;154(1):152-61. doi: 10.1002/jcp.1041540119. J Cell Physiol. 1993. PMID: 8419401 - Nonenzymatic glycosylation of proteins in vivo.
[No authors listed] [No authors listed] Nutr Rev. 1989 Sep;47(9):281-3. doi: 10.1111/j.1753-4887.1989.tb02866.x. Nutr Rev. 1989. PMID: 2689936 Review.
Cited by
- Relationship between advanced glycation end-products and advanced oxidation protein products in patients with type 2 diabetes with and without albuminuria: A cross-sectional survey.
Larry M, Rabizadeh S, Mohammadi F, Yadegar A, Jalalpour A, Mirmiranpour H, Farahmand G, Esteghamati A, Nakhjavani M. Larry M, et al. Health Sci Rep. 2024 Sep 29;7(10):e70057. doi: 10.1002/hsr2.70057. eCollection 2024 Oct. Health Sci Rep. 2024. PMID: 39355098 Free PMC article. - Ferroptosis-A Shared Mechanism for Parkinson's Disease and Type 2 Diabetes.
Duță C, Muscurel C, Dogaru CB, Stoian I. Duță C, et al. Int J Mol Sci. 2024 Aug 14;25(16):8838. doi: 10.3390/ijms25168838. Int J Mol Sci. 2024. PMID: 39201524 Free PMC article. Review. - Vitamin D in Type 2 Diabetes and Its Correlation With Heat Shock Protein 70, Ferric Reducing Ability of Plasma, Advanced Oxidation Protein Products and Advanced Glycation End Products.
Hashemi N, Karimpour Reyhan S, Qahremani R, Seifouri K, Tavakoli M, Seyedi SA, Ghaemi F, Abbaszadeh M, Esteghamati A, Nakhjavani M, Mirmiranpour H, Rabizadeh S. Hashemi N, et al. Endocrinol Diabetes Metab. 2024 Jul;7(4):e508. doi: 10.1002/edm2.508. Endocrinol Diabetes Metab. 2024. PMID: 39001578 Free PMC article. - Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite.
Sakai-Sakasai A, Takeda K, Suzuki H, Takeuchi M. Sakai-Sakasai A, et al. Biomolecules. 2024 Feb 8;14(2):202. doi: 10.3390/biom14020202. Biomolecules. 2024. PMID: 38397439 Free PMC article. Review. - Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications.
Rabbani N, Thornalley PJ. Rabbani N, et al. Front Endocrinol (Lausanne). 2024 Jan 16;14:1268308. doi: 10.3389/fendo.2023.1268308. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38292764 Free PMC article.
References
- Metabolism. 1989 Jul;38(7):649-54 - PubMed
- Nature. 1989 Jul 6;340(6228):70-2 - PubMed
- Proc Natl Acad Sci U S A. 1989 Jul;86(13):5141-5 - PubMed
- J Cell Biol. 1989 Aug;109(2):811-22 - PubMed
- Diabetes. 1989 Oct;38(10):1258-70 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous